Abstract
In order to investigate the efficacy of anthralin ( Anthraderm ) in the treatment of warts a randomized controlled trial was carried out in 72 patients. During a two-month period of treatment 56% were cured in the group treated with anthralin 2% ( Anthraderm ), evaluated at follow-up 2-9 months after finishing treatment, compared with 26% in the group treated with the comparative drug ( Verucid ). Anthralin 2% ( Anthraderm ) was found to have a significantly better effect, especially in the group of patients with warts solely on the hands.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Anthracenes / therapeutic use*
-
Anthralin / therapeutic use*
-
Child
-
Clinical Trials as Topic
-
Copper / therapeutic use*
-
Drug Combinations / therapeutic use
-
Humans
-
Lactates / therapeutic use
-
Lactic Acid*
-
Middle Aged
-
Organometallic Compounds*
-
Plant Extracts / therapeutic use*
-
Random Allocation
-
Salicylates / therapeutic use*
-
Skin Diseases / drug therapy*
-
Warts / drug therapy*
Substances
-
Anthracenes
-
Drug Combinations
-
Lactates
-
Organometallic Compounds
-
Plant Extracts
-
Salicylates
-
lactic acid, salicylic acid drug combination
-
Lactic Acid
-
Copper
-
Anthralin